Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	39.15	39.82	36.02	29.52	99.6	1.58
Short-Term Investments	110.48	139.66	91.44	98.23	-	-
Cash & Short-Term Investments	149.64	179.48	127.46	127.75	99.6	1.58
Cash Growth	36.06%	40.81%	-0.23%	28.26%	6192.04%	-
Prepaid Expenses	1.69	2.15	2.23	4.34	0.81	0.14
Total Current Assets	151.33	181.63	129.69	132.1	100.41	1.72
Property, Plant & Equipment	7.98	8.03	7.91	6.86	5.79	0.06
Long-Term Investments	15.2	5.09	-	41.88	-	-
Long-Term Deferred Charges	-	0.5	-	-	-	-
Other Long-Term Assets	1.85	1.35	0.67	0.39	0.39	0.41
Total Assets	176.35	196.59	138.27	181.23	106.59	2.19
Accounts Payable	3.69	0.76	5.05	0.9	0.96	0.14
Accrued Expenses	8.4	15.4	7.38	4.14	1.22	0.42
Short-Term Debt	-	-	-	-	-	0.06
Current Portion of Leases	1.11	1.06	0.88	0.73	0.66	-
Current Unearned Revenue	-	-	-	0.07	0.07	-
Other Current Liabilities	0.35	-	-	0.67	-	-
Total Current Liabilities	13.55	17.21	13.3	6.52	2.91	0.61
Long-Term Leases	2.41	2.59	3.77	4.24	4.96	-
Total Liabilities	15.96	19.8	17.07	10.75	7.88	0.61
Common Stock	0.03	0.03	0.02	0.02	0	0
Additional Paid-In Capital	376.73	373.28	237.68	226.58	1.05	0.21
Retained Earnings	-216.66	-196.98	-116.42	-56.03	-24.87	-8.62
Comprehensive Income & Other	0.28	0.45	-0.08	-0.1	-	-
Total Common Equity	160.39	176.79	121.2	170.48	-23.81	-8.41
Shareholders' Equity	160.39	176.79	121.2	170.48	98.71	1.57
Total Liabilities & Equity	176.35	196.59	138.27	181.23	106.59	2.19
Total Debt	3.51	3.65	4.64	4.96	5.63	0.06
Net Cash (Debt)	146.12	175.84	122.81	122.79	93.98	1.53
Net Cash Growth	38.46%	43.17%	0.02%	30.66%	6062.30%	-
Net Cash Per Share	3.87	5.20	5.56	29.79	53.90	1.06
Filing Date Shares Outstanding	31.36	31.35	22.64	21.92	1.77	1.43
Total Common Shares Outstanding	31.35	31.23	22.52	21.92	1.77	1.43
Working Capital	137.78	164.42	116.39	125.58	97.49	1.11
Book Value Per Share	5.12	5.66	5.38	7.78	-13.45	-5.87
Tangible Book Value	160.39	176.79	121.2	170.48	-23.81	-8.41
Tangible Book Value Per Share	5.12	5.66	5.38	7.78	-13.45	-5.87
Machinery	6.57	6.38	3.13	2.51	0.35	0.08
Construction In Progress	0.38	0.06	1.31	-	-	-

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q